BACKGROUND: While several studies have evaluated predictors for atrial fibrillation (AF) recurrence following catheter ablation, there are limited data specific to cryoballoon ablation (CBA). METHODS: We analyzed a prospective registry of patients at a single institution who underwent CBA. Recurrence of AF (RAF) was defined as recurrence of AF by 12-month follow-up, excluding the 3-month blanking period. Univariate analysis was performed to evaluate predictors of RAF. Receiver operating characteristic analysis was used to compare and evaluate the performance of various risk scores for discriminating risk of RAF. RESULTS: There were 542 patients included in the analysis with mean age 61.3 ± 10.6 years, 67.9% male, and 51.6% paroxysmal AF (PAF). Overall, only left atrial diameter (LAD) > 40 mm and ERAF (early recurrence of AF within 0-3 month blanking period) were significant predictors of RAF. In the PAF specific subgroup, LAD > 40 mm, AF duration > 12 months, prior stroke or transient ischemic attack, ERAF, and having previously failed an antiarrhythmic drug were significant predictors of RAF. In persistent AF (PeAF) subgroup, obstructive sleep apnea (OSA) and ERAF were significant predictors of RAF. Out of clinical risk scores tested, BASEAF2 had the highest performance with area under the curve of 0.646 (95% confidence interval [0.548, 0.708]; P < .01). CONCLUSIONS: In this single-center retrospective study of CBA, we found only LAD > 40 mm and ERAF to be predictors of RAF. We identified OSA as a potential targetable risk factor in PeAF patients undergoing CBA. Out of risk scores tested for discriminating risk of RAF, BASEAF2 had the best performance.
BACKGROUND: While several studies have evaluated predictors for atrial fibrillation (AF) recurrence following catheter ablation, there are limited data specific to cryoballoon ablation (CBA). METHODS: We analyzed a prospective registry of patients at a single institution who underwent CBA. Recurrence of AF (RAF) was defined as recurrence of AF by 12-month follow-up, excluding the 3-month blanking period. Univariate analysis was performed to evaluate predictors of RAF. Receiver operating characteristic analysis was used to compare and evaluate the performance of various risk scores for discriminating risk of RAF. RESULTS: There were 542 patients included in the analysis with mean age 61.3 ± 10.6 years, 67.9% male, and 51.6% paroxysmal AF (PAF). Overall, only left atrial diameter (LAD) > 40 mm and ERAF (early recurrence of AF within 0-3 month blanking period) were significant predictors of RAF. In the PAF specific subgroup, LAD > 40 mm, AF duration > 12 months, prior stroke or transient ischemic attack, ERAF, and having previously failed an antiarrhythmic drug were significant predictors of RAF. In persistent AF (PeAF) subgroup, obstructive sleep apnea (OSA) and ERAF were significant predictors of RAF. Out of clinical risk scores tested, BASEAF2 had the highest performance with area under the curve of 0.646 (95% confidence interval [0.548, 0.708]; P < .01). CONCLUSIONS: In this single-center retrospective study of CBA, we found only LAD > 40 mm and ERAF to be predictors of RAF. We identified OSA as a potential targetable risk factor in PeAF patients undergoing CBA. Out of risk scores tested for discriminating risk of RAF, BASEAF2 had the best performance.
Authors: Alan S Go; Kristi Reynolds; Jingrong Yang; Nigel Gupta; Judith Lenane; Sue Hee Sung; Teresa N Harrison; Taylor I Liu; Matthew D Solomon Journal: JAMA Cardiol Date: 2018-07-01 Impact factor: 14.676
Authors: F D'Ascenzo; A Corleto; G Biondi-Zoccai; M Anselmino; F Ferraris; L di Biase; A Natale; R J Hunter; R J Schilling; S Miyazaki; H Tada; K Aonuma; L Yenn-Jiang; H Tao; C Ma; D Packer; S Hammill; F Gaita Journal: Int J Cardiol Date: 2012-05-22 Impact factor: 4.164
Authors: Ethan M Balk; Ann C Garlitski; Alawi A Alsheikh-Ali; Teruhiko Terasawa; Mei Chung; Stanley Ip Journal: J Cardiovasc Electrophysiol Date: 2010-11
Authors: Wilber Su; Arash Aryana; Rod Passman; Gurjit Singh; Robert Hokanson; Marcin Kowalski; Jason Andrade; Paul Wang Journal: Heart Rhythm Date: 2018-04-20 Impact factor: 6.343
Authors: Ersan Akkaya; Alexander Berkowitsch; Sergej Zaltsberg; Harald Greiss; Christian W Hamm; Johannes Sperzel; Thomas Neumann; Malte Kuniss Journal: J Cardiovasc Electrophysiol Date: 2017-11-10
Authors: Ashish Shukla; Anthony Aizer; Douglas Holmes; Steven Fowler; David S Park; Scott Bernstein; Neil Bernstein; Larry Chinitz Journal: JACC Clin Electrophysiol Date: 2015-04-20
Authors: Karuna Chilukuri; Darshan Dalal; Shrirang Gadrey; Joseph E Marine; Edwin Macpherson; Charles A Henrikson; Alan Cheng; Saman Nazarian; Sunil Sinha; David Spragg; Ronald Berger; Hugh Calkins Journal: J Cardiovasc Electrophysiol Date: 2009-11-17
Authors: Ravi B Patel; Caitlin Somerville; Fei Fei Gong; Andrew C Peters; Sanjiv J Shah; Alexandru B Chicos; Susan Kim; Bradley P Knight; Albert Lin; Nishant Verma; Rod S Passman Journal: J Atr Fibrillation Date: 2020-04-30
Authors: Graham Lohrmann; Albert Liu; Paul Ziegler; João Monteiro; Nathan Varberg; Rod Passman Journal: J Interv Card Electrophysiol Date: 2022-08-02 Impact factor: 1.759
Authors: Marek Jastrzębski; Grzegorz Kiełbasa; Kamil Fijorek; Adam Bednarski; Aleksander Kusiak; Tomasz Sondej; Agnieszka Bednarek; Wiktoria Wojciechowska; Marek Rajzer Journal: J Arrhythm Date: 2021-05-20
Authors: Makoto Sano; Christian-Hendrik Heeger; Vanessa Sciacca; Niels Große; Ahmad Keelani; Behzad Hassan Hosseiny Fahimi; Huong Lan Phan; Samuel Reincke; Ben Brüggemann; Thomas Fink; Spyridon Liosis; Julia Vogler; Charlotte Eitel; Roland Richard Tilz Journal: J Interv Card Electrophysiol Date: 2020-07-07 Impact factor: 1.900
Authors: Anna Numminen; Tero Penttilä; Olli Arola; Jaakko Inkovaara; Niku Oksala; Heikki Mäkynen; Jussi Hernesniemi Journal: J Interv Card Electrophysiol Date: 2021-05-31 Impact factor: 1.900